Clinical Trials Logo

Brainstem Response clinical trials

View clinical trials related to Brainstem Response.

Filter by:
  • None
  • Page 1

NCT ID: NCT03835091 Completed - Brainstem Response Clinical Trials

Use of BRASS in Sedated Critically-ill Patients as a Predictable Mortality Factor

BRASS-ICU
Start date: February 7, 2019
Phase:
Study type: Observational

Sedation is used for 30 to 70 % of all intensive care unit (ICU) patients. Deep sedation can be used for lot of disease like acute respiratory distress syndrome, septic shock. Deep sedation was defined by RASS (Richmond Assessment Sedation Scale) below -3. Deep sedation can be associated with increased mortality, length stay, duration of mechanical ventilation, acute brain dysfunction. The french exploration neurologic group in ICU developed a score used Brainstem response patterns in patient deeply sedated by midazolam and showed that a high BRASS score is associated with high mortality at day 28. The investigators think that BRASS score isn't associated with the medication used for sedation. In this study the investigators included all patients sedated independently of medication used for sedation, we also excluded patient with neurologic disorder. The main objective is to shown that high BRASS score at admission of patient without neurologic disorder sedated is predictive of 28-day mortality.